Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. XTLB has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
XTLB stock price ended at $1.43 on , after rising10%
The X T L Biopharmaceuticals Ltd stock price increased by 10% on the last trading day (), rising from 1.32 to 1.43. Throughout the last trading session, the stock experienced a fluctuation of 12.87% , ranging from a day low of $1.32 to a day high of 1.4899. The price has declined in 5 of the last 10 days, resulting in a total change of 21.19% during this period. On the last day, trading volume decrease by 1.74K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 2.58K shares were traded, amounting to approximately 3.62K.
XTLB Technical Signals
XTLB(X T L Biopharmaceuticals Ltd Corp) has buy signals and sell signals now. The average turnover of XTLB over the last 5 trading days is NaN. Overall, the technical indicator signals lean more toward a outlook in the mid-term.
XTLB Moving Average Analysis
X T L Biopharmaceuticals Ltd's overall moving average trend leans more bullish as of Monday, April 28, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $, and $. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $, and $. A break-down below any of these levels will issue sell signals.
XTLB Short Selling Analysis
The short sale ratio of X T L Biopharmaceuticals Ltd(XTLB) as of is %, dropping from last trading day. With decreasing price from to .
Technical Signal
Technical Signals Summary
Sell
Buy
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
Bullish Signals
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No Data
Bearish Signals
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
No Data
XTLB
Name
Similarity
Up/Down
No Data
XTLB Seasonality Analysis
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying X T L Biopharmaceuticals Ltd (XTLB.O) stock in has the highest probability of a positive return (%), while has the lowest probability (%).
Performance Seasonality
The chart shows X T L Biopharmaceuticals Ltd. (XTLB)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy X T L Biopharmaceuticals Ltd (XTLB.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. XTLB has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying X T L Biopharmaceuticals Ltd (XTLB.O) stock in a year?
The radar chart shows that buying X T L Biopharmaceuticals Ltd (XTLB.O) stock in has the highest probability of a positive return (45.45%), while has the lowest probability (45.45%).
How has X T L Biopharmaceuticals Ltd. (XTLB)'s stock price performed over the past three years?
XTLB's stock price fell by in Invalid Date,in by
Which bull technical signals does XTLB have?
Bullish technical signals of XTLB include:
Which bearish technical signals does XTLB have?
Bearish technical signals of XTLB include:
Is XTLB a buy based on overall technical signals summary?
XTLB has 5 buy signals and 3 sell signals now. Overall the technical rating for XTLB is . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of XTLB.
What is the trend of X T L Biopharmaceuticals Ltd (XTLB)'s moving average?
X T L Biopharmaceuticals Ltd's overall moving average trend leans more bullish as of April 28 2025, with 2 negative signals and 2 positive signal.
What is price prediction for XTLB stock next month?
The price prediction chart for X T L Biopharmaceuticals Ltd (XTLB.O) stock, as of Invalid Date, forecasts a % change over the next month, based on its high correlation with stock patterns. The similarity between their price movements over the analyzed periods is %. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for XTLB Stock?
The price prediction for XTLB stock in 2025 is **$1.35**, driven by its recent acquisition of Social Proxy and potential revenue growth. However, risks such as financial losses could lower the price to **$0.87**.
What is price prediction 2030 for XTLB Stock?
XTLB stock is predicted to reach **$2.50 by 2030**, driven by its strategic acquisition of Social Proxy and stable operations despite regional conflicts. The stock currently trades at $1.27 with neutral technical indicators and potential upside from its expanded asset portfolio. However, risks like geopolitical tensions and cash flow challenges could impact long-term growth.